SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Revenue for the quarter ended  December 2024 of Rs. 1008.70 millions grew by 10.67 % from Rs. 911.41 millions.The Company's Net profit for the December 2024 quarter have declined marginally to Rs. 151.84  millions as against Rs. 191.20 millions reported during the corresponding quarter ended.The Operating Profit of the company witnessed a decrease to 234.91 millions from 281.12 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 1008.70 911.41 10.67 2642.05 2730.66 -3.25 3654.69 3115.29 17.31
Other Income 14.29 35.65 -59.92 569.60 555.99 2.45 588.09 98.08 499.60
PBIDT 234.91 281.12 -16.44 1134.69 1315.41 -13.74 1639.95 846.96 93.63
Interest 0.61 0.41 48.78 1.59 1.09 45.87 1.57 1.35 16.30
PBDT 234.30 280.71 -16.53 1133.10 1314.32 -13.79 1448.90 845.61 71.34
Depreciation 28.88 27.15 6.37 82.91 78.31 5.87 108.98 102.83 5.98
PBT 205.42 253.56 -18.99 1050.19 1236.01 -15.03 1339.92 742.78 80.39
TAX 53.58 62.36 -14.08 136.53 186.16 -26.66 258.69 187.51 37.96
Deferred Tax 0.29 -4.99 -105.81 3.12 -7.99 -139.05 -10.82 4.97 -317.71
PAT 151.84 191.20 -20.59 913.66 1049.85 -12.97 1081.23 555.27 94.72
Equity 223.76 223.65 0.05 223.76 223.65 0.05 223.65 223.65 0.00
PBIDTM(%) 23.29 30.84 -24.50 42.95 48.17 -10.85 44.87 27.19 65.05

Advanced Enzyme Share Price

299.00 -8.95 (-2.91%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×